# Immunophenotyping of Acute b Cell Lymphoblstic Leukemia

> **NCT04084327** · — · UNKNOWN · sponsor: **South Egypt Cancer Institute** · enrollment: 50 (estimated)

## Conditions studied

- Acute Leukemia

## Interventions

- **OTHER:** stastical analysis

## Key facts

- **NCT ID:** NCT04084327
- **Lead sponsor:** South Egypt Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2020-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2019-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04084327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04084327, "Immunophenotyping of Acute b Cell Lymphoblstic Leukemia". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04084327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*